Adaptive Radiotherapy and MRIs Based on Patients With Newly Diagnosed High-Grade Glioma
Condition(s):Glioblastoma; Anaplastic Astrocytoma; Astrocytoma; Anaplastic OligodendrogliomaLast Updated:February 6, 2024Recruiting
Include Studies Not Open or Pending
Condition(s):Glioblastoma; Anaplastic Astrocytoma; Astrocytoma; Anaplastic OligodendrogliomaLast Updated:February 6, 2024Recruiting
Condition(s):High-grade GliomaLast Updated:January 11, 2023Recruiting
Condition(s):High Grade GliomaLast Updated:December 26, 2023Recruiting
Condition(s):Glioma, MalignantLast Updated:January 29, 2024Recruiting
Condition(s):High-grade GliomaLast Updated:August 21, 2023Not yet recruiting
Condition(s):Recurrent High Grade GliomaLast Updated:February 23, 2024Recruiting
Condition(s):High Grade Glioma; Glioma; Glioma, Malignant; Neoplasms, Neuroepithelial; Neuroectodermal Tumors; Photosensitizing Agents; Neoplasm Malignant; Brain Neoplasms, Adult, Malignant; Central Nervous System Neoplasms; Brain Tumor; Tumour, ResidualLast Updated:May 9, 2023Not yet recruiting
Condition(s):High Grade Glioma; GlioblastomaLast Updated:March 5, 2024Recruiting
Condition(s):High Grade GliomaLast Updated:November 28, 2023Recruiting
Condition(s):High-grade GliomaLast Updated:January 11, 2024Not yet recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.